Collective Family Office’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,952
| Closed | -$266K | – | 166 |
|
|
2024
Q4 | $266K | Sell |
2,952
-333
| -10% | -$30K | 0.07% | 147 |
|
|
2024
Q3 | $325K | Buy |
3,285
+727
| +28% | +$71.8K | 0.09% | 139 |
|
|
2024
Q2 | $237K | Buy |
+2,558
| New | +$237K | 0.07% | 162 |
|
|
2023
Q3 | – | Sell |
-4,200
| Closed | -$349K | – | 181 |
|
|
2023
Q2 | $349K | Sell |
4,200
-150
| -3% | -$12.5K | 0.14% | 128 |
|
|
2023
Q1 | $332K | Sell |
4,350
-1,980
| -31% | -$151K | 0.14% | 126 |
|
|
2022
Q4 | $525K | Buy |
6,330
+1,770
| +39% | +$147K | 0.24% | 89 |
|
|
2022
Q3 | $362K | Buy |
4,560
+1,650
| +57% | +$131K | 0.18% | 118 |
|
|
2022
Q2 | $216K | Buy |
+2,910
| New | +$216K | 0.09% | 174 |
|